Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Controlled Clinical Study of Allogeneic Stem Cell Transplantation With Reduced Conditioning (RICT) Versus Best Standard of Care in Acute Myeloid Leukemia (AML)in First Complete Remission (CR)

NCT00342316 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT00342316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00342316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Controlled Clinical Study of Allogeneic Stem Cell Transplantation With Reduced Conditioning (RICT) Versus Best Standard of Care in Acute Myeloid Leukemia (AML)in First Complete Remission (CR)
Lead sponsor
Vastra Gotaland Region
Phase
Not applicable
Overall status
Completed
Start date
December 18, 2003
Completion date
July 20, 2018
Enrollment
340 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia